Sudden Death Between Morphological Arguments And Assumptions- Case Report von Carabulea, Adelina Ioana, Nicolae, Anamaria, Pricop, Ş., Bitca, R., Deacu, S., Neculai-Candea, Lavinia, Popa, M. F.

Volltext

Legal Norms Regarding the Assessment of the Ability to Drive Motor Vehicles von M., Popa, C., Rebeleanu, S., Pricop, L., Neculai-Candea

Volltext

Vascular Adhesive Peptide-1 (VAP-1) Expression in Wounds – A New Vital Reaction Marker? von Deacu, S., Neculai-Candea, L., Pricop, S., Aschie, M., Mocanu, L., Popa, M.F.

Volltext

VIRUS-ASSOCIATED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS – THE SEVERE COURSE EXPRESSION IN SARS-COV-2 INFECTION? von Popa, MF, Deacu, S, Candea, LN, Comanici, SR, Pricop, S, Mocanu, L, Gheju, A, Tabirca, DD

Volltext

Reaction Conditions Study in Linear H-Functional Polysiloxane Synthesis von Hamciuc, Viorica, Pricop, Lucia, Marcu, Mihai, Ionescu, Catalin, Sacarescu, Liviu, Simona Pricop, Denisa

Volltext

The Sentinel Node Assessment in Cervical Cancer von Pricop, M.S., Cocos, M., Musca, S., Strat, L., Slatineanu, S.

Volltext

Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis von Mease, Philip J, McInnes, Iain B, Kirkham, Bruce, Kavanaugh, Arthur, Rahman, Proton, van der Heijde, Désirée, Landewé, Robert, Nash, Peter, Pricop, Luminita, Yuan, Jiacheng, Richards, Hanno B, Mpofu, Shephard

Volltext

Genome-wide association analysis identifies variation in vitamin D receptor and other host factors influencing the gut microbiota von Wang, Jun, Thingholm, Louise B, Skiecevičienė, Jurgita, Rausch, Philipp, Kummen, Martin, Hov, Johannes R, Degenhardt, Frauke, Heinsen, Femke-Anouska, Rühlemann, Malte C, Szymczak, Silke, Holm, Kristian, Esko, Tönu, Sun, Jun, Pricop-Jeckstadt, Mihaela, Al-Dury, Samer, Bohov, Pavol, Bethune, Jörn, Sommer, Felix, Ellinghaus, David, Berge, Rolf K, Hübenthal, Matthias, Koch, Manja, Schwarz, Karin, Rimbach, Gerald, Hübbe, Patricia, Pan, Wei-Hung, Sheibani-Tezerji, Raheleh, Häsler, Robert, Rosenstiel, Philipp, D'Amato, Mauro, Cloppenborg-Schmidt, Katja, Künzel, Sven, Laudes, Matthias, Marschall, Hanns-Ulrich, Lieb, Wolfgang, Nöthlings, Ute, Karlsen, Tom H, Baines, John F, Franke, Andre

Volltext

Secukinumab provides sustained PASDAS-defined remission in psoriatic arthritis and improves health-related quality of life in patients achieving remission: 2-year results from the... von Coates, L C, Gladman, D D, Nash, P, FitzGerald, O, Kavanaugh, A, Kvien, T K, Gossec, L, Strand, V, Rasouliyan, L, Pricop, L, Ding, K, Jugl, S M, Gaillez, C

Volltext

Interpenetrating poly(urethane-urea)polydimethylsiloxane networks designed as active elements in electromechanical transducers von Tugui, C, Vlad, S, Iacob, M, Varganici, C. D, Pricop, L, Cazacu, M

Volltext

TIME SPENT BY BLOWFLY LUCILIA SERICATA ON STANDARD TRAPS BAITED WITH LIVER AND AMMONIA von FLORICA MORARIU, B. LIXANDRU, S. MORARIU, ANCA PRICOP

Volltext

Difficulties in implementing the dietary regimen in obese lithiasic patients von Pricope, C.G.

Volltext

Comparison of remission and low disease activity states with DAPSA, MDA and VLDA in a clinical trial setting in psoriatic arthritis patients: 2-year results from the FUTURE 2 study von Coates, Laura C., Nash, Peter, Kvien, Tore K., Gossec, Laure, Mease, Philip J., Rasouliyan, Lawrence, Pricop, Luminita, Jugl, Steffen M., Gandhi, Kunal K., Gaillez, Corine, Smolen, Josef S.

Volltext

Laser Induced Dyeing (LID) with Reactive Blue 21 on Hemp Fibers von Cocean, A, Cocean, I, Postolachi, C, Pricop, D, Husanu, F, Gurlui, S

Volltext

SAT0579 Secukinumab Safety and Tolerability in Patients with Active Psoriatic Arthritis: Pooled Safety Analysis of Two Phase 3, Randomized, Controlled Trials (Future 1 and Future 2... von Mease, P., McInnes, I.B., Richards, H., Pricop, L., Widmer, A., Mpofu, S.

Volltext

THU0421 Secukinumab is Effective in Reducing Dactylitis and Enthesitis Using Multiple Measures in Patients with Psoriatic Arthritis: Data from a Phase 3 Randomized, Multicenter, Do... von Kirkham, B., McInnes, I.B., Mease, P., Kremer, J., Kandala, S., Pricop, L., Mpofu, S.

Volltext

THU0433 Secukinumab Improves Physical Function, Quality of Life, Fatigue and Work Productivity in Patients with Active Psoriatic Arthritis in Future 2, A Phase 3 Trial von Rahman, P., Strand, V., McInnes, I.B., Marzo-Ortega, H., Dokoupilová, E., Churchill, M., Kandala, S., Pricop, L., Mpofu, S.

Volltext

184 Secukinumab provides sustained remission and low disease activity related to disease activity index for psoriatic arthritis: two year results from the FUTURE 2 study von McInnes, Iain, Smolen, Josef S, Kvien, Tore K, Pricop, Luminita, Fox, Todd, Rasouliyan, Lawrence, Jugl, Steffen, Gaillez, Corine

Volltext

182 Secukinumab provides sustained improvement in function, quality of life and fatigue over two years in patients who achieved disease activity index for psoriatic arthritis remis... von McInnes, Iain, Smolen, Josef S, Gossec, Laure, Strand, Vibeke, Pricop, Luminita, Fox, Todd, Jugl, Steffen, Gaillez, Corine

Volltext

THU0414 Secukinumab Inhibits Radiographic Progression in Patients with Psoriatic Arthritis: Data from a Phase 3 Randomized, Multicenter, Double-Blind, Placebo-Controlled Study (Fut... von van der Heijde, D., Landewé, R., Mease, P., McInnes, I.B., Conaghan, P.G., Pricop, L., Ligozio, G., Richards, H., Mpofu, S.

Volltext